Tiny eye implant becomes the first FDA-approved therapy for rare blindness-Click Here

Aug. 29, 2025 — For people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vision, there have long been no approved treatment options. But now, a new study sponsored by Neurotech Pharmaceuticals and …Read More